Design and evaluation of small molecules that target the dimerization interface of full-length and splice-variant forms of the androgen receptor as a potential treatment for advanced prostate cancer
Design and evaluation of small molecules that target the dimerization interface of full-length and splice-variant forms of the androgen receptor as a potential treatment for advanced prostate cancer
批准号:
370554
负责人:
Cherkasov Artem
金额:
$33.44万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-09-01 至 2020-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer continues to be a leading cause of death for men in North America The main factor that drives the transformation that changes normal prostate tissue into cancerous lesions is the androgen receptor (AR), a molecular signalling protein, whic
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Network - Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.
-
批准号:443064
-
项目类别:Operating Grants
-
资助金额:$6.56万
-
财政年份:2021
-
负责人:Cherkasov Artem
-
依托单位:
COVID-19 Variant Supplement - Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.
-
批准号:443137
-
项目类别:Operating Grants
-
资助金额:$3.64万
-
财政年份:2021
-
负责人:Cherkasov Artem
-
依托单位:
Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.
-
批准号:429444
-
项目类别:Operating Grants
-
资助金额:$153.65万
-
财政年份:2020
-
负责人:Cherkasov Artem
-
依托单位:
Sex as a Biological Variable Supplement - Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease
-
批准号:424703
-
项目类别:Operating Grants
-
资助金额:$3.64万
-
财政年份:2020
-
负责人:Cherkasov Artem
-
依托单位:
Canada Research Chair - Tier 1
-
批准号:453866
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2020
-
负责人:Cherkasov Artem
-
依托单位:
Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease
-
批准号:422705
-
项目类别:Operating Grants
-
资助金额:$72.78万
-
财政年份:2020
-
负责人:Cherkasov Artem
-
依托单位:
First-in-Class Small-molecule Inhibitors Selectively Targeting the DNA-binding Domain of Human Androgen Receptor and Its Splice Variants for the Treatment of Resistant Prostate Cancer
-
批准号:308059
-
项目类别:Operating Grants
-
资助金额:$10.93万
-
财政年份:2014
-
负责人:Cherkasov Artem
-
依托单位:
Next generation anti-androgens for the treatment of castration-resistant prostate cancers
-
批准号:251984
-
项目类别:Operating Grants
-
资助金额:$50.1万
-
财政年份:2012
-
负责人:Cherkasov Artem
-
依托单位:
海外基金